CliffBio
small molecule

XYLOCAINE 1.5% W/ DEXTROSE 7.5%

LIDOCAINE HYDROCHLORIDE

Loss of exclusivity—loss of exclusivity
CompanyFresenius Kabi →See this company's full patent-cliff portfolio

Drug detail

Brand nameXYLOCAINE 1.5% W/ DEXTROSE 7.5%
Active ingredientLIDOCAINE HYDROCHLORIDE
Strength1.5%
Dosage formINJECTABLE
RouteSPINAL
ModalitySmall molecule
Marketing statusDISCN

More from Fresenius Kabi

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.